United States · FDA National Drug Code directory

Guaifenesin and Dextromethorphan HBR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43598-115_aea829a5-fc5d-7453-c533-dc4af59c329e
Product NDC
43598-115
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Guaifenesin and Dextromethorphan HBR
Labeler
Dr. Reddy's Laboratories Inc.
Marketing category
ANDA
Marketing start / end (source format)
20230815
Source listing expiry
20261231

Source-listed ingredients

  • GUAIFENESIN — 1200 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 4 BLISTER PACK in 1 CARTON (43598-115-28) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-115-28
  • 2 BLISTER PACK in 1 CARTON (43598-115-32) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-115-32
  • 3 BLISTER PACK in 1 CARTON (43598-115-37) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (43598-115-74) · 43598-115-37
  • 6 BLISTER PACK in 1 CARTON (43598-115-42) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-115-42
  • 4 BLISTER PACK in 1 CARTON (43598-115-56) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (43598-115-74) · 43598-115-56
  • 1 BLISTER PACK in 1 CARTON (43598-115-70) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-115-70

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →